GO:0006505 GPI anchor metabolic process: Biosynthesis, Remodeling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006505 (GPI anchor metabolic process) describes the chemical reactions and pathways that build, attach, and remodel glycosylphosphatidylinositol (GPI) anchors, which tether proteins to the lipid bilayer.
• The core GPI structure is phosphatidylinositol linked via inositol C-6 to a carbohydrate chain that ends in ethanolamine phosphate, which forms an amide bond with the protein C-terminus.
• More than 20 PIG genes catalyze the stepwise biosynthesis of GPI anchors in the endoplasmic reticulum membrane.
• After attachment, GPI-anchored proteins undergo remodeling of their lipid and carbohydrate moieties, which influences their trafficking and membrane dynamics.
• Defects in GPI anchor metabolism cause inherited diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and multiple congenital disorders of glycosylation.
• CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of individual GPI pathway genes.
Description
GPI anchor metabolic process (GO:0006505) encompasses the chemical reactions and pathways involving glycosylphosphatidylinositol anchors, which are complex glycolipids that attach proteins to the cell membrane. These anchors are essential for the correct localization and function of many cell-surface proteins, including receptors, adhesion molecules, and enzymes. The process includes the biosynthesis of the GPI anchor in the endoplasmic reticulum, its covalent attachment to proteins, and subsequent remodeling events that occur in the secretory pathway. Researchers study GPI anchor metabolism because it is fundamental to eukaryotic cell biology and because its disruption leads to severe human diseases. The pathway is highly conserved from yeast to humans, and the enzymes involved are attractive targets for therapeutic intervention. Understanding the molecular details of GPI anchor biosynthesis, attachment, and remodeling provides insights into membrane protein trafficking, signal transduction, and host-pathogen interactions. This article integrates authoritative QuickGO data with published literature to provide a comprehensive overview of GO:0006505, covering its definition, biological importance, key genes, regulatory mechanisms, disease associations, and experimental models. It is designed for researchers who need a concise yet thorough resource for studying GPI anchor metabolic process.
GPI anchor metabolic process At A Glance
| GO ID | GO:0006505 |
|---|---|
| GO term | GPI anchor metabolic process |
| Ontology | biological_process |
| Synonym | glycosylphosphatidylinositol metabolic process; glycosylphosphatidylinositol metabolism; GPI anchor metabolism; GPI/GSI anchor metabolic process; GPI/GSI anchor metabolism |
| Major function | Biosynthesis, attachment, and remodeling of glycosylphosphatidylinositol anchors that tether proteins to the cell membrane |
| Subcellular location | Endoplasmic reticulum membrane and Golgi apparatus |
| Key enzymes | PIG family proteins (e.g., PIGA, PIGB, PIGC, PIGF, PIGG, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGX, PIGY, PIGZ) |
| Representative substrates | Phosphatidylinositol, UDP-N-acetylglucosamine, mannose, ethanolamine phosphate |
| Associated diseases | Paroxysmal nocturnal hemoglobinuria (PNH), multiple congenital disorders of glycosylation (e.g., MCAHS, HPMRS) |
What Is GO:0006505?
GPI anchor metabolic process (GO:0006505) is defined as the chemical reactions and pathways involving glycosylphosphatidylinositol anchors, which are molecular mechanisms for attaching membrane proteins to the lipid bilayer of cell membranes. Structurally, a GPI anchor consists of a phosphatidylinositol molecule linked via the C-6 hydroxyl of the inositol to a carbohydrate chain. This chain is in turn linked to the protein through an ethanolamine phosphate group, the amino group of which is in amide linkage with the C-terminal carboxyl of the protein chain, and the phosphate group is esterified to the C-6 hydroxyl of the terminal mannose of the core carbohydrate chain.
Why Is GPI anchor metabolic process Important in Cell Biology?
GPI anchor metabolic process is critically important because it governs the expression and function of a large class of cell-surface proteins that lack transmembrane domains. These GPI-anchored proteins participate in diverse biological processes, including cell signaling, immune recognition, complement regulation, and cell adhesion. Disruption of GPI anchor biosynthesis leads to severe inherited disorders, and acquired mutations in the PIGA gene cause paroxysmal nocturnal hemoglobinuria. Moreover, GPI anchors are essential for the virulence of certain protozoan parasites, such as Trypanosoma brucei, making the pathway a potential drug target. Studying this process also illuminates fundamental mechanisms of protein sorting and membrane dynamics.
• GPI anchors are essential for the membrane attachment of many cell-surface proteins, including enzymes, receptors, and adhesion molecules.
• The pathway is conserved across eukaryotes, from yeast to humans, facilitating model organism studies.
• Defects in GPI anchor biosynthesis cause paroxysmal nocturnal hemoglobinuria (PNH) and inherited glycosylphosphatidylinositol deficiency syndromes.
• GPI-anchored proteins are involved in signal transduction, immune response, and complement regulation.
• GPI anchor remodeling affects protein trafficking and membrane microdomain association.
• The pathway is a target for antiparasitic drug development, as GPI anchors are critical for Trypanosoma brucei survival.
• GPI-anchored prion protein (PrP) is implicated in neurodegenerative diseases.
• Understanding GPI anchor metabolism can inform the design of engineered cell therapies and biopharmaceuticals.
• CRISPR screens have identified GPI pathway genes as essential in various cancer cell lines.
• The pathway intersects with lipid metabolism and glycosylation, linking to broader metabolic networks.
What Happens During GPI anchor metabolic process?
Biosynthesis of the GPI anchor in the endoplasmic reticulum
In simple terms: The cell builds the GPI anchor step by step in the endoplasmic reticulum membrane.
GPI anchor biosynthesis begins on the cytoplasmic side of the endoplasmic reticulum (ER) membrane with the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI), catalyzed by the PIGA/PIGC/PIGH complex. Subsequent steps add three mannose residues and an ethanolamine phosphate (EtNP) group, forming the complete GPI anchor precursor. This precursor is then flipped into the ER lumen, where it is further modified and attached to proteins. The entire process requires more than 20 distinct gene products, many of which are encoded by PIG genes.
Attachment of the GPI anchor to proteins
In simple terms: The finished anchor is glued onto the tail end of a protein.
In the ER lumen, the GPI transamidase complex (composed of PIGK, PIGS, PIGT, PIGU, and GPAA1) recognizes proteins with a C-terminal GPI attachment signal peptide and replaces this signal with the pre-assembled GPI anchor. The transamidase cleaves the signal peptide and forms an amide bond between the ethanolamine phosphate of the GPI anchor and the new C-terminus of the protein. This covalent attachment is essential for the protein to remain associated with the membrane.
Remodeling of the GPI anchor
In simple terms: After attachment, the anchor is fine-tuned by removing or adding chemical groups.
Following attachment, GPI-anchored proteins undergo remodeling in the ER and Golgi apparatus. This includes the removal of the inositol-linked acyl chain by PGAP1, the removal of an ethanolamine phosphate from the second mannose by PGAP5, and the addition of a palmitate to the inositol ring by PGAP2/PGAP3. These modifications influence the protein's trafficking, association with lipid rafts, and stability at the cell surface. Remodeling is critical for the proper function of GPI-anchored proteins in signaling and cell adhesion.
Transport and surface expression of GPI-anchored proteins
In simple terms: The finished GPI-anchored protein is shipped to the cell surface.
After remodeling, GPI-anchored proteins are transported from the ER to the Golgi and then to the plasma membrane. The GPI anchor acts as a sorting signal that directs proteins to specific membrane microdomains, such as lipid rafts. At the cell surface, GPI-anchored proteins can be released by phospholipases (e.g., PI-PLC) or internalized via endocytosis. The dynamic regulation of surface expression is important for processes like signal transduction and immune recognition.
Turnover and degradation of GPI anchors
In simple terms: Old anchors are broken down and recycled.
GPI-anchored proteins can be cleaved by endogenous phospholipases, releasing the protein and leaving the GPI anchor in the membrane. The anchor can then be degraded by lipases and glycosidases. Turnover of GPI-anchored proteins is important for maintaining membrane homeostasis and for regulating signaling events. Defects in degradation can lead to accumulation of GPI intermediates, which may be toxic.
Key Genes Involved in GO:0006505 GPI anchor metabolic process
The following table lists key genes and proteins involved in GPI anchor metabolic process, along with their major roles and relevance for research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGA | Catalyzes the first step of GPI biosynthesis (transfer of GlcNAc to PI) | Mutations cause PNH; essential for GPI anchor production |
| PIGB | Adds the third mannose to the GPI core | Defects cause inherited glycosylphosphatidylinositol deficiency |
| PIGC | Part of the GPI-GlcNAc transferase complex | Required for GPI biosynthesis; knockout is lethal in mice |
| PIGF | Second mannosyltransferase | Mutations linked to congenital disorders of glycosylation |
| PIGG | Adds ethanolamine phosphate to the second mannose | Defects cause intellectual disability and seizures |
| PIGK | Catalytic subunit of GPI transamidase | Essential for GPI attachment; mutations cause GPI deficiency |
| PIGL | De-N-acetylase involved in GPI biosynthesis | Mutations cause CHIME syndrome |
| PIGM | First mannosyltransferase | Defects cause inherited GPI deficiency with thrombosis |
| PIGN | Involved in GPI biosynthesis | Mutations cause multiple congenital anomalies-hypotonia-seizures syndrome |
| PIGO | Ethanolamine phosphate transferase | Mutations cause hyperphosphatasia with mental retardation syndrome |
| PIGP | Regulates GPI biosynthesis | Defects cause early-onset epileptic encephalopathy |
| PIGQ | Part of GPI-GlcNAc transferase complex | Mutations cause epileptic encephalopathy |
| PIGS | Component of GPI transamidase | Required for GPI attachment; defects cause GPI deficiency |
| PIGT | Component of GPI transamidase | Mutations cause multiple congenital anomalies-hypotonia-seizures syndrome |
| PIGU | Component of GPI transamidase | Essential for GPI transamidase activity |
| PIGV | Second mannosyltransferase | Mutations cause hyperphosphatasia with mental retardation syndrome |
| PIGW | Involved in GPI biosynthesis | Defects cause West syndrome |
| PIGY | Component of GPI-GlcNAc transferase complex | Mutations cause intellectual disability |
| PGAP1 | Removes inositol-linked acyl chain during remodeling | Regulates GPI-anchored protein trafficking |
| PGAP2 | Adds palmitate to inositol during remodeling | Required for stable surface expression of GPI-anchored proteins |
| PGAP3 | Removes ethanolamine phosphate from second mannose | Involved in GPI remodeling; defects cause hyperphosphatasia |
How Is GPI anchor metabolic process Regulated?
GPI anchor metabolic process is regulated at multiple levels. Transcription of PIG genes can be induced by cellular stress and during differentiation. The activity of GPI biosynthetic enzymes is modulated by feedback inhibition and substrate availability. Remodeling enzymes such as PGAP1 and PGAP3 are regulated by their localization and by signaling pathways that control ER-Golgi trafficking. Additionally, the expression of GPI-anchored proteins at the cell surface is influenced by phospholipases and endocytic recycling. In pathogenic protozoa, GPI biosynthesis is developmentally regulated, with stage-specific expression of enzymes.
GPI anchor metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGA | Paroxysmal nocturnal hemoglobinuria (PNH) | PIGA knockout in hematopoietic stem cells; mouse models |
| PIGN | Multiple congenital anomalies-hypotonia-seizures syndrome | Patient-derived iPSCs; PIGN knockout mice |
| PIGO | Hyperphosphatasia with mental retardation syndrome | PIGO knockout cell lines; zebrafish models |
| PGAP1 | GPI remodeling defects; intellectual disability | PGAP1 knockout mice; neuronal cell lines |
| PRNP | Prion diseases | PRNP knockout mice; GPI anchor-deficient PrP knock-in mice |
Paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria is an acquired hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, which is X-linked. Loss of PIGA function leads to a deficiency of all GPI-anchored proteins on the surface of affected blood cells. This includes the complement regulators CD55 and CD59, rendering red blood cells susceptible to complement-mediated lysis. Patients present with hemolytic anemia, thrombosis, and bone marrow failure. The disease is a classic example of how a defect in GPI anchor biosynthesis causes human pathology.
Inherited GPI deficiencies (IGDs)
Inherited mutations in various PIG genes cause a spectrum of rare congenital disorders known as inherited GPI deficiencies (IGDs). These conditions are characterized by intellectual disability, epilepsy, hypotonia, and distinctive facial features. Examples include multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS) caused by PIGA, PIGN, or PIGT mutations, and hyperphosphatasia with mental retardation syndrome (HPMRS) caused by PIGO, PIGV, or PGAP3 mutations. These disorders highlight the critical role of GPI anchor metabolism in neurodevelopment.
Prion diseases
The prion protein (PrP) is a GPI-anchored glycoprotein that is central to the pathogenesis of transmissible spongiform encephalopathies, such as Creutzfeldt-Jakob disease. The GPI anchor is important for PrP localization to lipid rafts and for its conversion into the infectious PrPSc form. Studies have shown that GPI anchor attachment is required for PrP neurotoxicity in some models. Thus, GPI anchor metabolism is directly linked to neurodegenerative disease mechanisms.
Cancer
GPI-anchored proteins are overexpressed in many cancers and contribute to tumor growth, invasion, and immune evasion. For example, the GPI-anchored protein CEA (carcinoembryonic antigen) is a biomarker for colorectal cancer. Additionally, GPI anchor biosynthesis is essential for the survival of some cancer cells, as shown by CRISPR screens. Targeting GPI pathway enzymes may offer therapeutic opportunities.
From GPI anchor metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PIGA loss on GPI-anchored protein surface expression? | PIGA knockout cell lines (e.g., HEK293, HeLa) |
| How do point mutations in PIGT affect GPI transamidase activity? | Point mutation knock-in cell lines using CRISPR |
| Can we tag endogenous PIGK to study its localization? | Knock-in of fluorescent tags (e.g., GFP) at the PIGK locus |
| Does overexpression of PGAP2 enhance GPI-anchored protein surface levels? | Overexpression cell lines with inducible PGAP2 |
| What is the role of GPI anchor remodeling in lipid raft association? | PGAP1/PGAP3 knockout cells and lipid raft fractionation |
| Can we identify novel regulators of GPI anchor metabolism? | Genome-wide CRISPR knockout library screening |
How to Study the GPI anchor metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and fitness | Identifying novel GPI pathway genes |
| Flow cytometry | Surface expression of GPI-anchored proteins | Diagnosis of PNH; validating knockout phenotypes |
| Metabolic labeling | Biosynthesis and remodeling of GPI anchors | Tracking GPI intermediates |
| Mass spectrometry | Structural characterization of GPI anchors | Determining GPI anchor composition |
| Proximity labeling (BioID) | Protein-protein interactions | Mapping GPI enzyme interactome |
| Immunofluorescence microscopy | Subcellular localization of GPI-anchored proteins | Studying trafficking and lipid raft association |
| Western blotting | Protein expression and processing | Assessing GPI transamidase activity |
| RNA-seq | Transcriptional changes in GPI pathway genes | Evaluating regulation under stress |
CRISPR-Cas9 knockout screening
Genome-wide CRISPR knockout screens can identify genes essential for GPI anchor metabolism. Cells are transduced with a lentiviral sgRNA library, and after selection, sgRNA enrichment or depletion is measured by next-generation sequencing. This approach has been used to discover novel regulators of GPI biosynthesis and to confirm known PIG genes.
Flow cytometry for GPI-anchored proteins
Flow cytometry using antibodies against GPI-anchored proteins (e.g., CD55, CD59) or fluorescently labeled proaerolysin (which binds GPI anchors) allows quantification of surface GPI-anchored protein levels. This method is widely used to diagnose PNH and to assess GPI anchor deficiency in mutant cells.
Metabolic labeling and mass spectrometry
Cells can be metabolically labeled with radioactive precursors (e.g., [3H]mannose) or click-chemistry tags to follow GPI biosynthesis. Mass spectrometry can identify GPI intermediates and their modifications. These techniques provide detailed structural information about GPI anchors and their remodeling.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with GPI biosynthetic enzymes. Proximity labeling (e.g., BioID) can map the interactome of GPI transamidase components. These methods reveal the protein networks that regulate GPI anchor metabolism.
How CRISPR Can Be Used to Study GO:0006505 GPI anchor metabolic process
Knockout
CRISPR-Cas9 knockout of GPI pathway genes (e.g., PIGA, PIGK) in cell lines abolishes GPI anchor biosynthesis, leading to loss of all GPI-anchored proteins from the cell surface. This phenotype can be monitored by flow cytometry using proaerolysin or antibodies against GPI-anchored proteins. Knockout models are invaluable for studying the consequences of GPI deficiency and for validating gene function.
Point Mutation
Point mutations in GPI pathway genes identified in patients can be introduced into cell lines using CRISPR-Cas9 homology-directed repair (HDR) or base editing. These models allow researchers to study the specific effects of disease-associated mutations on enzyme activity, protein stability, and GPI anchor synthesis. For example, point mutations in PIGT can be knocked into HEK293 cells to assess transamidase function.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at endogenous GPI pathway gene loci enables real-time imaging and biochemical analysis of the tagged proteins. This approach preserves endogenous regulation and can reveal subcellular localization and dynamics. Knock-in of reporter genes can also be used to monitor GPI anchor levels.
Overexpression
Overexpression of GPI pathway genes (e.g., PGAP2, PIGA) using lentiviral or inducible systems can enhance GPI anchor production and surface expression of GPI-anchored proteins. This is useful for studying gain-of-function effects, for producing recombinant GPI-anchored proteins, and for testing whether increased GPI anchor levels affect cell signaling or adhesion.
How EDITGENE Supports GPI anchor metabolic process Research
Researchers studying GPI anchor metabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, how mutations affect protein function, and what the downstream consequences are for cell biology and disease. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from generating knockout cell lines to performing genome-wide screens and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for GPI anchor metabolic process research.
Frequently Asked Questions About GPI anchor metabolic process
What is GPI anchor metabolic process?
GPI anchor metabolic process (GO:0006505) is the set of chemical reactions and pathways that build, attach, and remodel glycosylphosphatidylinositol anchors, which are glycolipid structures that attach proteins to the cell membrane.
What genes are involved in GPI anchor metabolic process?
Over 20 genes are involved, including PIGA, PIGB, PIGC, PIGF, PIGG, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGY, PGAP1, PGAP2, and PGAP3.
What diseases are associated with GPI anchor metabolic process?
Defects in GPI anchor metabolism cause paroxysmal nocturnal hemoglobinuria (PNH) and inherited GPI deficiencies (IGDs) that present with intellectual disability, epilepsy, and congenital anomalies.
How is GPI anchor metabolic process studied?
Common methods include CRISPR knockout screens, flow cytometry for GPI-anchored proteins, metabolic labeling, mass spectrometry, and proteomics.
What is the role of PIGA in GPI anchor metabolism?
PIGA catalyzes the first step of GPI biosynthesis, transferring N-acetylglucosamine to phosphatidylinositol. Mutations in PIGA cause PNH.
What is GPI anchor remodeling?
GPI anchor remodeling refers to post-attachment modifications of the GPI anchor, such as removal of acyl chains or addition of palmitate, which affect protein trafficking and function.
Can CRISPR be used to study GPI anchor metabolic process?
Yes, CRISPR-Cas9 can generate knockout, point mutation, knock-in, and overexpression models for GPI pathway genes, enabling functional studies.
What is the structure of a GPI anchor?
A GPI anchor consists of phosphatidylinositol linked via inositol to a carbohydrate chain that ends in ethanolamine phosphate, which forms an amide bond with the protein C-terminus.
Where does GPI anchor biosynthesis occur?
GPI anchor biosynthesis occurs in the endoplasmic reticulum membrane, with subsequent remodeling in the ER and Golgi.
What are GPI-anchored proteins?
GPI-anchored proteins are proteins attached to the cell membrane via a glycosylphosphatidylinositol anchor, lacking a transmembrane domain.
Conclusion
GPI anchor metabolic process (GO:0006505) is a fundamental biological pathway that governs the biosynthesis, attachment, and remodeling of glycosylphosphatidylinositol anchors, which are essential for the membrane localization and function of numerous cell-surface proteins. Defects in this pathway lead to severe human diseases, including paroxysmal nocturnal hemoglobinuria and inherited GPI deficiencies. The pathway is also critical for the virulence of certain parasites and is implicated in cancer and neurodegeneration. Advances in CRISPR-based genome editing and screening technologies have greatly accelerated research into GPI anchor metabolism, enabling precise genetic models and high-throughput discovery. EDITGENE offers a comprehensive suite of services to support these studies, from custom knockout and knock-in cell lines to genome-wide screens and bioinformatics analysis. By leveraging these tools, researchers can deepen our understanding of GPI anchor biology and develop novel therapeutic strategies.
References
- 1. Kinoshita T. 2020. Biosynthesis and biology of mammalian GPI-anchored proteins.. Open Biol 10(3):190290 PMID: 32156170
- 2. Brown D et al.. 1992. Glycosyl-phosphatidylinositol-anchored membrane proteins.. J Am Soc Nephrol 3(4):895-906 PMID: 1450366
- 3. Ikezawa H. 2002. Glycosylphosphatidylinositol (GPI)-anchored proteins.. Biol Pharm Bull 25(4):409-17 PMID: 11995915
- 4. Hong Y et al.. 2009. Trypanosome glycosylphosphatidylinositol biosynthesis.. Korean J Parasitol 47(3):197-204 PMID: 19724691
- 6. Sarnataro D et al.. 2017. Cell Biology of Prion Protein.. Prog Mol Biol Transl Sci 150:57-82 PMID: 28838675
- 7. Fujita M et al.. 2012. GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics.. Biochim Biophys Acta 1821(8):1050-8 PMID: 22265715
- 8. Liu YS et al.. 2020. Mammalian GPI-anchor modifications and the enzymes involved.. Biochem Soc Trans 48(3):1129-1138 PMID: 32573677
